文献速递细菌感染、耐药与抗菌药物医院感染防控

加拿大医院10年CANWARD监测:42,936株病原菌药敏结果

42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

CANWARD监测研究于2007年建立,每年评估加拿大医院患者分离细菌对多种抗菌药物的体外敏感性。

要点

  • 菌株主要来自血液(43.5%)、呼吸道(33.1%)、尿液(13.2%)和伤口(10.2%)标本。
  • 最常见病原菌为金黄色葡萄球菌(21.2%)、大肠埃希菌(19.6%)和铜绿假单胞菌(9.0%)。

核心结论

  • CANWARD监测研究提供了加拿大医院常见感染病原菌10年的参考药敏数据。

主要发现

  • 菌株来源构成:血液43.5%、呼吸道33.1%、尿液13.2%、伤口10.2%。
  • 患者科室分布:内科病房29.9%、急诊24.8%、ICU 19.0%、医院门诊18.1%、外科病房8.2%。
  • 患者人口学:男性54.6%、女性45.4%;年龄≤17岁13.1%、18-64岁44.3%、≥65岁42.7%。
  • 最常见病原菌:金黄色葡萄球菌21.2%(含MSSA和MRSA)、大肠埃希菌19.6%、铜绿假单胞菌9.0%。
  • 大肠埃希菌对美罗培南和替加环素敏感率99.9%,对厄他培南和多粘菌素99.8%,对阿米卡星99.7%,对头孢他啶/阿维巴坦和普拉佐米星99.6%。

临床怎么用

  • 监测数据可为加拿大医院常见病原菌的经验性抗菌治疗提供参考。
  • MRSA对万古霉素、利奈唑胺等敏感率较高,可指导MRSA感染治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The CANWARD surveillance study was established in 2007 to annually assess the in vitro susceptibilities of a variety of antimicrobial agents against bacterial pathogens isolated from patients receiving care in Canadian hospitals. METHODS: 42 936 pathogens were received and CLSI broth microdilution testing was performed on 37 355 bacterial isolates. Limited patient demographic data submitted with each isolate were collated and analysed. RESULTS: Of the isolates tested, 43.5%, 33.1%, 13.2% and 10.2% were from blood, respiratory, urine and wound specimens, respectively; 29.9%, 24.8%, 19.0%, 18.1% and 8.2% of isolates were from patients in medical wards, emergency rooms, ICUs, hospital clinics and surgical wards. Patient demographics associated with the isolates were: 54.6% male/45.4% female; 13.1% patients aged ≤17 years, 44.3% 18-64 years and 42.7% ≥65 years. The three most common pathogens were Staphylococcus aureus (21.2%, both methicillin-susceptible and MRSA), Escherichia coli (19.6%) and Pseudomonas aeruginosa (9.0%). E. coli were most susceptible to meropenem and tigecycline (99.9%), ertapenem and colistin (99.8%), amikacin (99.7%) and ceftolozane/tazobactam and plazomicin (99.6%). Twenty-three percent of S. aureus were MRSA. MRSA were most susceptible to ceftobiprole, linezolid and telavancin (100%), daptomycin (99.9%), vancomycin (99.8%) and tigecycline (99.2%). P. aeruginosa were most susceptible to ceftolozane/tazobactam (98.3%) and colistin (95.0%). CONCLUSIONS: The CANWARD surveillance study has provided 10 years of reference antimicrobial susceptibility testing data on pathogens commonly causing infections in patients attending Canadian hospitals.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Zhanel GG, Adam HJ, Baxter MR, et al. 42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study. J Antimicrob Chemother. 2019. PMID: 31505641. doi:10.1093/jac/dkz283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。